Milton C. Ault III - 15 Feb 2023 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
10%+ Owner
Signature
/s/ Milton C. Ault, III
Issuer symbol
ALZN
Transactions as of
15 Feb 2023
Net transactions value
+$597
Form type
4
Filing time
17 Feb 2023, 20:55:20 UTC
Previous filing
13 Feb 2023
Next filing
20 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $597 +1,000 +0.01% $0.5973 11,051,001 15 Feb 2023 By Ault Lending, LLC F1
holding ALZN Common Stock 2,500,000 15 Feb 2023 Direct
holding ALZN Common Stock 365,000 15 Feb 2023 By Ault Alpha LP F2
holding ALZN Common Stock 14,942,984 15 Feb 2023 By Ault Life Sciences, Inc. F3
holding ALZN Common Stock 10,000,000 15 Feb 2023 By Ault Life Sciences Fund, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AA"). Mr. Ault, the Executive Chairman of AA, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F2 Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.